TIDMNSCI

RNS Number : 7571F

NetScientific PLC

16 November 2015

NetScientific PLC

("NetScientific" or the "Group")

London, UK - 16 November 2015: NetScientific PLC (AIM: NSCI.L), a transatlantic biomedical healthcare group, announces that it will today apply to admit, in total, 54,167 ordinary shares of 5p each to trading on AIM. Admission is expected on 20 November 2015 and these shares will rank pari passu with the existing ordinary shares in issue.

These shares are being subscribed for by a small number of employees who expressed an interest to the Board in acquiring shares in the Company, but who were unable to as part of the recent fundraising as they were not existing shareholders in NetScientific. None of these employees are directors of the Company. The subscription price is equal to that of the recent fundraising, announced on 1 October 2015, being 120 pence per ordinary share

On Admission, the Company's issued share capital will comprise 51,075,695 Ordinary Shares, none of which will be held in treasury. This figure may be used by shareholders and other investors as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules

-Ends-

 
 
 Contact Details 
   NetScientific plc                             Tel: +44 (0)20 3514 
                                                                1800 
   François Martelet, CEO 
   Peter Thoms, CFO 
 
   Investec Bank plc (NOMAD & Broker)            Tel: +44 (0)20 7597 
    Gary Clarence                                               4000 
    Daniel Adams 
 
   Instinctif Partners                      Tel: +44 (0)20 7457 2020 
    Melanie Toyne-Sewell                netscientific@instinctif.com 
    Jayne Crook 
    Rosanna Forrest

About NetScientific

NetScientific is a transatlantic biomedical and healthcare technology group with a differentiated investment strategy focused solely on digital health, diagnostics and therapeutics. The Group's objective is to source, fund and commercialise companies that significantly improve the lives of people with chronic diseases.

For more information, please visit the website at www.netscientific.net.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEPKPDQABDDADD

(END) Dow Jones Newswires

November 16, 2015 02:00 ET (07:00 GMT)

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Netscientific.
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Netscientific.